ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0006474 | null | Butane (substance)|n-butane|butane|n-Butane|Butane|n-Butane (substance)|BUTANE | butane |
C1419860 | null | SODIUM CHANNEL, NEURONAL TYPE II, BETA SUBUNIT|sodium voltage-gated channel beta subunit 2|SCN2B|SCN2B gene|SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, BETA SUBUNIT|SODIUM CHANNEL, VOLTAGE-GATED, BETA-2 SUBUNIT | SCN2B gene |
C1419860 | null | SODIUM CHANNEL, NEURONAL TYPE II, BETA SUBUNIT|sodium voltage-gated channel beta subunit 2|SCN2B|SCN2B gene|SODIUM CHANNEL, VOLTAGE-GATED, TYPE II, BETA SUBUNIT|SODIUM CHANNEL, VOLTAGE-GATED, BETA-2 SUBUNIT | SCN2B gene |
C0256371 | A cytoplasmic serine threonine kinase involved in regulating CELL DIFFERENTIATION and CELLULAR PROLIFERATION. Overexpression of this enzyme has been shown to promote PHOSPHORYLATION of BCL-2 PROTO-ONCOGENE PROTEINS and chemoresistance in human acute leukemia cells. | PKC-alpha Serine-Threonine Kinase|Protein Kinase C alpha|PKC alpha Serine Threonine Kinase|Protein Kinase C-alpha|Serine-Threonine Kinase, PKC-alpha|Protein Kinase C(alpha) | Protein Kinase C Alpha |
C0256371 | A cytoplasmic serine threonine kinase involved in regulating CELL DIFFERENTIATION and CELLULAR PROLIFERATION. Overexpression of this enzyme has been shown to promote PHOSPHORYLATION of BCL-2 PROTO-ONCOGENE PROTEINS and chemoresistance in human acute leukemia cells. | PKC-alpha Serine-Threonine Kinase|Protein Kinase C alpha|PKC alpha Serine Threonine Kinase|Protein Kinase C-alpha|Serine-Threonine Kinase, PKC-alpha|Protein Kinase C(alpha) | Protein Kinase C Alpha |
C0063690 | Recombinases that insert exogenous DNA into the host genome. Examples include proteins encoded by the POL GENE of RETROVIRIDAE and also by temperate BACTERIOPHAGES, the best known being BACTERIOPHAGE LAMBDA. | Integrase|Integrases|integrase | Integrase |
C0870134 | Someone from whom you are descended (but usually more remote than a grandparent). | Ancestors|Progenitor|ancestors | Ancestor |
C0283827 | null | EF 1alpha|EF-1alpha | Elongation Factor 1alpha |
C0075189 | A ubiquitous phosphoprotein that serves as an intracellular substrate for a variety of SIGNAL TRANSDUCTION PATHWAYS. PHOSPHORYLATION of stathmin occurs during CELL CYCLE progression, and stathmin functions as a microtubule-destabilizing protein that promotes MICROTUBULE depolymerization during INTERPHASE and late MITOSIS. Stathmin is expressed at very high levels in a variety of human CANCERS. | Prosolin|Lap18 Protein|Metablastin|Leukemia Associated Phosphoprotein p18|Phosphoprotein, Op18|p19, Phosphoprotein|Stathmin|Op18 Phosphoprotein|Oncoprotein 18|stathmin|Phosphoprotein p18|Leukemia-Associated Phosphoprotein p18|p18, Phosphoprotein|Phosphoprotein p19|p18, Leukemia-Associated Phosphoprotein|oncoprotein 18 | Stathmin |
C1335424 | null | Plantar Verrucous Carcinoma of Skin|Plantar Verrucous Carcinoma of the Skin | Plantar Verrucous Skin Carcinoma |
C1335424 | null | Plantar Verrucous Carcinoma of Skin|Plantar Verrucous Carcinoma of the Skin | Plantar Verrucous Skin Carcinoma |
C1335424 | null | Plantar Verrucous Carcinoma of Skin|Plantar Verrucous Carcinoma of the Skin | Plantar Verrucous Skin Carcinoma |
C1258971 | null | ZM-447439|ZM447439 | ZM 447439 |
C0031610 | A glycerol backbone covalently bound to a phosphate group in one position, and fatty acids in the 2nd and 3rd positions. Phosphatidic acids thus have a polar head and apolar tails, and occur in cell membranes throughout nature. | Phosphatidic acid (substance)|Phosphatidic acid|Phosphatidic Acid|phosphatidic acid|Acid, Phosphatidic|Glycerophosphoric Acid | Phosphatidic Acid |
C0072980 | A macrolide compound obtained from Streptomyces hygroscopicus that acts by selectively blocking the transcriptional activation of cytokines thereby inhibiting cytokine production. It is bioactive only when bound to IMMUNOPHILINS. Sirolimus is a potent immunosuppressant and possesses both antifungal and antineoplastic properties. | Sirolimusum|Sirolimús|RAPAMYCIN|sirolimus|(-)-Rapamycin|Sirolimus (substance)|Sirolimus|SLM|RAPA|SIROLIMUS|Sirolimus-containing product|Product containing sirolimus (medicinal product)|Rapamycin|9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,2|rapamycin | sirolimus |
C0010815 | Plant hormones that promote the separation of daughter cells after mitotic division of a parent cell. Frequently they are purine derivatives. | Cytokinins (substance)|Cytokinins|cytokinins|cytokinin | Cytokinins |
C0936060 | null | indolyl-3-acetic acid|3-indolylacetic acid|indole-3-acetic acid|Indoleacetic acid (substance)|IES cpd|Indoleacetic acid|indole acetic acid|beta-indoleacetic acid|3-indoleacetic acid|1H-Indole-3-acetic acid|indoleacetic acid|Indoleacetic acid preparation|heteroauxin | Indoleacetic acid |
C0042629 | The etiologic agent of CHOLERA. | Bacillo virgola del Koch|V. cholerae|Pacinia cholerae-asiaticae|Spirillum cholerae|Vibrio comma|Bacillus cholerae-asiaticae|v. cholerae|vibrio cholerae|Vibrio cholerae biovar albensis|Vibrio cholera|vibrio cholera|Vibrio albensis|Liquidivibrio cholerae|Vibrio cholerae (organism)|Vibrio cholerae|Microspira comma|Vibrio cholerae-asiaticae|Spirillum cholerae-asiaticae|Vibrio cholerae bv. albensis|Kommabacillus|cholera vibrio|VIBRIO CHOLERAE|Bacillus cholerae|cholerae vibrio | Vibrio cholerae |
C0008831 | null | cis 4 Hydroxyproline | cis-4-Hydroxyproline |
C0911440 | null | (PhAc-Tyr(1),Arg(2),Phe(4-Cl)(6),Arg(9),Abu(15),Nle(27),Arg(28),Har(29))hGH-RH(1-29)NH2|GHRH (1-29)-NH2, phenylacetyl-tyrosyl(1)-arginyl(2)-4-chlorophenylalanyl(6)-arginyl(9)-2-aminobutanoyl(15)-norleucyl(27)-arginyl(28)-homoarginyl(29)-|JV-1-36|GHRH (1-29)-NH2, phenylacetyl-Tyr(1)-Arg(2)-Phe(4-Cl)(6)-Arg(9)-Abu(15)-Nle(27)-Arg(28)-Har(29)- | JV 1-36 |
C0656934 | null | JS-114 | JS 114 |
C1521871 | Addition of extra material. | Amplification | Amplification |
C1442161 | Loss of a DNA sequence that contains one or more genes. This typically occurs via rearrangement, whereby DNA sequences that are normally separated become joined together. A gene deletion abnormality can be either heritable or somatic. | Gene Deletion Abnormality|Deletion|Deletion (morphologic abnormality)|Gene Deletion | Gene Deletion Abnormality |
C0333693 | A very rare congenital syndrome characterized by the presence of three haploid sets of chromosomes. The surviving infants have multiple severe birth defects. | Triploid|Triploidy Syndrome|Triploidies|Triploids|Triploidy (morphologic abnormality)|Triploidy syndrome (disorder)|Triploid Syndrome|triploidy|Triploidy syndrome|Triploidy|triploidy syndrome | Triploidy syndrome |
C0206476 | Cell surface receptors that bind specific neuropeptides with high affinity and trigger intracellular changes influencing the behavior of cells. Many neuropeptides are also hormones outside of the nervous system. | Receptors, Neuropeptide|Neuropeptides Receptors|Neuropeptide Receptors|neuropeptide receptor|Neuropeptide Receptor|neuropeptide receptors|Receptors, Neuropeptides|Receptor, Neuropeptide | Neuropeptide Receptor |
C1336789 | Transcription Repressor/Corepressor Gene encodes Transcriptional Repressor/Corepressor, proteins that can regulate transcription by binding to the operator and causing repression. (from Glick: Glossary of Biochemistry and Molecular Biology) | Transcriptional Repressor/Corepressor|Transcriptional Corepressor|Transcription Repressor|Transcriptional Repressor|Repressor|Transcription Corepressor | Transcription Repressor/Corepressor |
C0687675 | expulsion of the products of conception before the completion of gestation. | Pregnancy Loss|pregnancy loss|loss pregnancy|losses pregnancy | Pregnancy loss |
C0000912 | null | Accident caused by unspecified fire|fire accident|Burning NOS|fire | Accident caused by unspecified fire |
C0025921 | One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. | C57BL Mouse|Mice, C57BL|C57BL Mice, Inbred|Mouse, Inbred C57BL|C57BL|Inbred C57BL Mice|C57BL Mice|C57BL Mouse, Inbred|Inbred C57BL Mouse|Mouse, C57BL | Mice, Inbred C57BL |
C0302912 | null | Radical, NOS|radical|Radical (substance)|Radical|radicals | Radicals (chemistry) |
C0002144 | A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. | 4-Hydroxy-1H-pyrazolo(3,4-d)pyrimidine|Allopurinol (substance)|4-Hydroxypyrazolopyrimidine|Allopurinolum|Product containing allopurinol (medicinal product)|ALLOPURINOL|allopurinol|4-Hydroxypyrazolo[3,4-d]pyrimidine|Allopurinol-containing product|1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidine-4-one|1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one|Alopurinol|4-Hydroxypyrazolyl(3,4-d)pyrimidine|4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-|4-Hydroxy-3,4-pyrazolopyrimidine|Allopurinol|4-hydroxypyrazolo[3,4-d]pyrimidine|1H-Pyrazolo(3,4-d)pyrimidin-4-ol|4H-Pyrazolo(3,4-d)pyrimidin-4-one|4-HPP|4'-Hydroxypyrazolol(3,4-d)pyrimidine|1H-Pyrazolo[3,4-d]pyrimidin-4-ol|1,5-Dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one|4-Hydroxypyrazolo(3,4-d)pyrimidine|1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one|4'-HPP | allopurinol |
C0282774 | diamine oxidase and nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications. | Guanyl hydrazine|hydrazinecarboximidamide|Hydrazinecarboximidamide|PIMAGEDINE|Pimagedine|pimagedine|monoaminoguanidine|Aminate base|Monoaminoguanidine|aminoguanidine|Aminoguanidine | pimagedine |
C0591350 | null | desferal|Desferal | Desferal |
C0591350 | null | desferal|Desferal | Desferal |
C0047645 | A tyrosine derivative with a nitro group attached to carbon 3 on the phenyl ring that is a product of tyrosine nitration mediated by reactive nitrogen species, including peroxynitrite anion and nitrogen dioxide. 3-nitrotyrosine is a biomarker of cell damage, inflammation, and NO (nitric oxide) production; it is overproduced in many diseases where oxidative stress plays a key role. | 3-Mononitrotyrosine|3-mononitrotyrosine|nitrotyrosine|3-Nitrotyrosine|3-NT|Tyrosine, 3-Nitro- | 3-nitrotyrosine |
C1383860 | Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix. | cardiac hypertrophy|Heart Hypertrophy|Heart--Hypertrophy|heart hypertrophy|Cardiac Hypertrophy|Cardiac hypertrophy | Cardiac Hypertrophy |
C1511518 | Refers to the genetic trait involving the number of copies of a particular gene present in the genome of an individual. Genetic variants, including insertions, deletions, and duplications of segments of DNA, are also collectively referred to as copy number variants. Copy number variants account for a significant proportion of the genetic variation between individuals. | CNV|Copy Number Polymorphism|CNP|DNA Copy Number Polymorphism|Polymorphisms, Copy Number|Polymorphism, Copy Number|Copy Number Alteration|copy number variant|Copy Number Variation|CNA|DNA Copy Number Polymorphisms|Copy Number Polymorphisms | Copy Number Polymorphism |
C1512032 | Any mutation that encodes an altered gene product that acts to antagonize the wild-type allele. Dominant negative mutations are characterized by a dominant or semi-dominant phenotype, and usually result in loss of function. | Dominant-Negative Mutation|Dominant-Negative Mutation Abnormality|Dominant-Negative Mutant|Dominant Negative | Dominant-Negative Mutation |
C0027481 | A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. | atriopeptin|Natriuretic Peptides, Atrial|Atrial natriuretic factor (substance)|Atrial Natriuretic Factor|Atrial natriuretic peptides|atrial natriuretic peptide (ANP)|ANP|Atrial natriuretic peptide|Atriopeptins|ANH (atrial natriuretic hormone)|atrial natriuretic factor (ANF)|ANH - atrial natriuretic hormone|Atrial natriuretic hormone|atriopeptins|atrial natriuretic peptide|Atriopeptin|Atrial Natriuretic Peptides|Peptides, Atrial Natriuretic|auriculin|ANP - atrial natriuretic peptide|atrial natriuretic hormone|A-type natriuretic peptide|Auriculin|Atrial natriuretic factor|atrial natriuretic peptides|atrial natriuretic factor|anf|ANF|anp | Atrial Natriuretic Factor |
C0326625 | null | Gnatcatcher|Gnatcatcher, NOS|Gnatcatcher (organism) | Gnatcatcher (organism) |
C0009221 | A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). | Codon|Codons|codon|codons | Codon (nucleotide sequence) |
C0284965 | Bacterial proteins that are used by BACTERIOPHAGES to incorporate their DNA into the DNA of the "host" bacteria. They are DNA-binding proteins that function in genetic recombination as well as in transcriptional and translational regulation. | Integration Host Factor|Host Factors, Integration|Factors, Integration Host|Host Factor Protein | Integration Host Factors |
C0027150 | The type species of LEPORIPOXVIRUS causing infectious myxomatosis, a severe generalized disease, in rabbits. Tumors are not always present. | Myxomatosis Virus|Myxoma viruses|Myxomatosis Viruses|Myxoma virus|Poxvirus Myxomatis|myxoma virus|myxoma virus MYX|Myxoma virus (organism) | Myxoma virus |
C0035111 | A family of unenveloped RNA viruses with cubic symmetry. The twelve genera include ORTHOREOVIRUS; ORBIVIRUS; COLTIVIRUS; ROTAVIRUS; Aquareovirus, Cypovirus, Phytoreovirus, Fijivirus, Seadornavirus, Idnoreovirus, Mycoreovirus, and Oryzavirus. | Respiratory Enteric Orphan Viruses|Family Reoviridae (organism)|Reoviridae|Family Reoviridae|Reovirus|Respiratory Enteric Orphan Virus | Reoviridae |
C0040642 | A group of carrier proteins which bind with VITAMIN B12 in the BLOOD and aid in its transport. Transcobalamin I migrates electrophoretically as a beta-globulin, while transcobalamins II and III migrate as alpha-globulins. | Vitamin B12 binding protein|Vitamin B12 Binding Proteins|Cobalamin-Binding Proteins|Vitamin B12-Binding Proteins|Proteins, Cobalamin-Binding|TC|Transcobalamin, NOS|Cobalamin Binding Proteins|Proteins, Vitamin B12-Binding|Vitamin B 12-Binding Proteins|transcobalamin|transcobalamins|Transcobalamins|Transcobalamin|Vitamin B<sub>12</sub> binding protein|Vitamin B12 Binding Protein|Vitamin B 12 Binding Proteins|Cobalamin binding protein|Transcobalamin (substance)|Vitamin B>12< binding protein|TCN | Transcobalamin |
C0174989 | null | null | projectin |
C0174989 | null | null | projectin |
C0017976 | covering the sugar hydrolases. | Glycoside Hydrolases|glycoside hydrolases|Glycosidase (substance)|Glycohydrolases|Glycosidases|Hydrolases, Glycoside|Glycosidase|glycosidase | Glycoside Hydrolases |
C1167351 | A plant cell wall that is no longer able to expand and so does not permit growth. Secondary cell walls contain less pectin that primary cell walls. The secondary cell is mostly composed of cellulose and is strengthened with lignin. [GOC:jid, ISBN:0943088399] | null | secondary cell wall |
C0024803 | null | null | Mariana Islands |
C0024803 | null | null | Mariana Islands |
C0039617 | Protein synthesized by CLOSTRIDIUM TETANI as a single chain of ~150 kDa with 35% sequence identity to BOTULINUM TOXIN that is cleaved to a light and a heavy chain that are linked by a single disulfide bond. Tetanolysin is the hemolytic and tetanospasmin is the neurotoxic principle. The toxin causes disruption of the inhibitory mechanisms of the CNS, thus permitting uncontrolled nervous activity, leading to fatal CONVULSIONS. | Tetanus Toxins|Toxins, Tetanus|Toxin, tetanus|Tetanus Toxin|tetanus toxin|Toxin, Clostridium tetani|Clostridium tetani toxin (substance)|Tetanus toxin|Clostridium tetani Toxin|TETANUS TOXIN|Clostridium tetani toxin|Toxin, Tetanus | tetanus toxin |
C0005515 | Endogenously-synthesized compounds that influence biological processes not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS. | Biological products|Biologics|biological factors|Factor, Biological|Biological Agents|biological product|biological products|agents biological|Agents, Biological|biopharmaceutical|Factors, Biologic|Biological Factor|Biological agent (product)|biologic agent|Biologicals|biological drug|Factor, Biologic|biotherapeutic agent|Factors, Biological|biological substances|biological substance|Agents, Biologic|biologics|biopharmaceuticals|Biologic Factor|Biologic Factors|Biological agent, NOS|Biological Products|Biological substance (substance)|Biological Drug|Biological substance|Biological Factors|Biologic|Biologic Agents|BIOLOGIC|Biological Agent|Biopharmaceuticals|Biological agent|biological agent | Biological Factors |
C1332410 | This gene is involved in the regulation of apoptosis. | BH3-INTERACTING DOMAIN DEATH AGONIST|BID Gene|BID|BID gene|BH3 interacting domain death agonist|BH3 Interacting Domain Death Agonist Gene | BID gene |
C0056820 | null | null | cyclosporin diaziridine |
C0056820 | null | null | cyclosporin diaziridine |
C0579220 | A genus of gram-negative, facultatively anaerobic rods. It is a saprophytic, marine organism which is often isolated from spoiling fish. | SHEWANELLA|Shewanella species|Genus Shewanella (organism)|Genus Shewanella|Shewanella | Shewanella |
C0006531 | null | BW284C51|BW-284-C-51 | BW 284 C 51 |
C0242827 | Tandem arrays of moderately repetitive, short (10-60 bases) DNA sequences which are found dispersed throughout the GENOME, at the ends of chromosomes (TELOMERES), and clustered near telomeres. Their degree of repetition is two to several hundred at each locus. Loci number in the thousands but each locus shows a distinctive repeat unit. | Minisatellite|Minisatellite Repeats|Variable Number Tandem Repeat|Variable Number of Tandem Repeats|Minisatellites|minisatellite repeats|Minisatellite Repeat|VNTR|Repeats, Minisatellite|Repeat, Minisatellite | Minisatellite Repeats |
C0009170 | An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. | Cocaina|methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|(-)-cocaine|Methyl benzoylecgonine|Cocaine-containing product|Coke|Neurocaine|(-)-Cocaine|Cocaine|Coca|Cocain|Cocainum|2-methyl-3β-hydroxy-1αH,5αH-tropane-2β-carboxylate benzoate (ester)|C|L-Cocaine|cocaine in any form|Product containing cocaine (medicinal product)|[1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|beta-Cocain|L-Cocain|cocaine|cocaine substance|COCAINE|(1R,2R,3S,5S)-2-Methoxycarbonyltropan-3-yl Benzoate|Snow|Kokain|cocaine product|Blow|8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))-|Cocaine (substance) | cocaine |
C0031790 | A genus of zygomycetous fungi in the family Mucoraceae, order MUCORALES, forming mycelia having a metallic sheen. It has been used for research on phototropism. | Phycomyces (organism)|phycomyces|Phycomyce|Phycomyces|Phycomyces species | Phycomyces |
C1276996 | null | 2nd Generation/Atypical|antipsychotic atypical|antipsychotics atypical|atypical antipsychotic | Atypical antipsychotic |
C1514762 | An intercellular process that involves a cellular receptor binding to a cognate ligand and results in a specific cellular response. | null | Receptor Signaling |
C0036751 | A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. | 1H-Indol-5-ol, 3-(2-aminoethyl)-|Serotonin|5-Hydroxy tryptamine|5-ht|5-HT|SEROTONIN|5ht|Serotonin (substance)|5 hydroxytryptamine|Hippophaine|5 ht|5-HT - 5-hydroxytryptamine|serotonins|thrombocytin|5-hydroxytryptamine|sérotonine|5-Hydroxytryptamine|5-hydroxy tryptamine|5 Hydroxytryptamine|thrombotonin|5HT|serotonin|3-(2-Aminoethyl)-1H-indol-5-ol|Enteramine|5 hydroxy tryptamine | serotonin |
C0107053 | Cell surface receptors that bind BRADYKININ and related KININS with high affinity and trigger intracellular changes which influence the behavior of cells. The identified receptor types (B-1 and B-2, or BK-1 and BK-2) recognize endogenous KALLIDIN; t-kinins; and certain bradykinin fragments as well as bradykinin itself. | Bradykinin Receptors|Receptors, Bradykinin|Receptor, Bradykinin|Bradykinin Receptor | Bradykinin Receptor |
C1150423 | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. [ISBN:0198506732] | kinase activity|phosphokinase activity | kinase activity |
C0265252 | An inherited syndrome caused by mutations in the RPS6KA3 gene. It is characterized by mental retardation, developmental delay, microcephaly, short stature and kyphoscoliosis. | coffin lowry syndrome|Coffin Syndrome|Coffin Lowry Syndrome|coffin-lowry syndrome|Coffin-Lowry syndrome|Coffin-Lowry Syndrome|CLS|Mental Retardation with Osteocartilaginous Abnormalities|Syndrome, Coffin|COFFIN-LOWRY SYNDROME|Syndrome, Coffin-Lowry|CLS - Coffin-Lowry syndrome|syndrome coffin lowry|Coffin-Lowry syndrome (disorder) | Coffin-Lowry syndrome |
C0073366 | null | iron-sulfur protein Rieske|Rieske iron-sulfur protein | Rieske iron-sulfur protein |
C0030958 | A structural polymer of the bacterial cell envelope consisting of sugars and amino acids which is responsible for both shape determination and cellular integrity under osmotic stress in virtually all bacteria. | Peptidoglycans|Peptidoglycan|peptidoglycan|Murein|murein | Peptidoglycan |
C0931513 | null | Helix of auricle of right ear|Helix of right pinna|Right helix|Helical part of right pinna | Right helix |
C0443146 | A specific humoral or cell-mediated immune response against autologous (self) antigens. An autoimmune process may produce or be caused by autoimmune disease and may be developmentally complex, not necessarily pathological, and possibly pervasive. | Autoimmune reaction (finding)|Autoimmune Process|Autoimmune process (qualifier value)|autoimmune reactions|Autoimmune|Autoimmune process|AUTOIMMUNE REACTIONS|Autoimmune Reaction|Autoimmune reaction, NOS|autoimmune reaction|Reaction, Autoimmune|Autoimmune Reactions|Autoimmune reaction|AI - autoimmune | Autoimmune reaction |
C1334043 | A gene from one species which corresponds to a gene in another species and that is related via a common ancestral species. These genes retain a similar sequence and function. | Homolog|Gene Homolog|Homologous|Homologous Gene|Homologous Association|Homologue|Homology | Homologous Gene |
C1136031 | The process in which double-stranded RNAs silence cognate genes. Involves posttranscriptional gene inactivation ('silencing') both of transgenes or dsRNA introduced into a germline, and of the host gene(s) homologous to the transgenes or dsRNA. This silencing is triggered by the introduction of transgenes or double-stranded RNA (dsRNA), and can occur through a specific decrease in the level of mRNA, or by negative regulation of translation, of both host genes and transgenes. [GOC:ems, PMID:11201747, PMID:11713190, PMID:18771919] | post-transcriptional gene silencing|Silencing, Post-Transcriptional Gene|posttranscriptional gene silencing by siRNA|RNA interference|Posttranscriptional Gene Silencing|RNA interference (RNAi)|Post-Transcriptional Gene Silencings|rnai|Gene Silencing, Post Transcriptional|Interference, RNA|Gene Silencings, Posttranscriptional|rna interference|RNA Silencing|PTGS|Post Transcriptional Gene Silencing|Gene Silencing, Posttranscriptional|quelling|Quelling|Gene Silencing, Post-Transcriptional|RNA Interference|cosuppression|Post-Transcriptional Gene Silencing|posttranscriptional gene silencing|RNAi|Sequence-Specific Posttranscriptional Gene Silencing | RNA Interference |
C0007292 | Proteins that bind or transport specific substances in the blood, within the cell, or across cell membranes. | transport proteins|carrier protein|Transport Protein|Carrier protein, NOS|Carrier proteins|Transport Proteins|Carrier protein|Proteins, Carrier|Transport protein, NOS|carrier proteins|Transporter Protein|transport protein|Proteins, Transport|Carrier Protein|Transport protein|Carrier protein (substance) | Carrier Proteins |
C1258910 | null | N formylmethionyl leucyl phenylalanine | N-formylmethionyl-leucyl-phenylalanine |
C0027103 | The subfamily of myosin proteins that are commonly found in muscle fibers. Myosin II is also involved a diverse array of cellular functions including cell division, transport within the GOLGI APPARATUS, and maintaining MICROVILLI structure. | Myosin-II|Myosin Type II|Myosin II | Myosin Type II |
C1268443 | null | cell normal|cells normal|Normal cell|Normal cell (cell)|normal cell | Normal cell |
C0248561 | null | laminin A|alpha1 laminin|laminin alpha1 | laminin A |
C0005187 | null | beta Actinin | beta-Actinin |
C0008864 | A non-essential amino acid. In hepatocytes, L-citrulline is synthesized in the urea cycle by the addition of carbon dioxide and ammonia to ornithine. L-citrulline is converted into L-arginine by the enzymes argininosuccinate synthetase and argininosuccinate lyase in the presence of L-aspartate and ATP. Subsequently, L-arginine is converted to nitric oxide by nitric oxide synthase and L-citrulline is regenerated as a by-product. | 2-Amino-5-(carbamoylamino)pentanoic Acid|l-citrulline|N5-(Aminocarbonyl)-L-ornithine|L-Ornithine, N5-(aminocarbonyl)-|L-2-Amino-5-ureidovaleric acid|N5-(Aminocarbonyl)ornithine|N5-carbamoylornithine|citrulline|(S)-2-Amino-5-ureidopentanoic acid|2-Amino-5-ureidovaleric acid|Citrulina|delta-Ureidonorvaline|Product containing citrulline (medicinal product)|Citrulline (substance)|alpha-amino-delta-Ureidovaleric acid|N(5)-(Aminocarbonyl)-L-ornithine|N(delta)-Carbamylornithine|N5-Carbamoyl-L-ornithine|CITRULLINE|Cit|α-amino-δ-ureidovaleric acid|Citrulline-containing product|δ-ureidonorvaline|L-citrulline|Citrulline|L-Citrulline|2-amino-5-(carbamoylamino)pentanoic acid | citrulline |
C0675237 | null | haemagglutinin 1 | hemagglutinin I |
C0178443 | null | JEWISH|Jewish, follower of religion|jewish|Jewish, follower of religion (person)|jew|jews|jewish [follower of religion]|Jew|Jewish | Jewish, follower of religion |
C1511024 | A mutation that is typically a heritable, permanent change in the nucleotide sequence of the BRCA2 gene. Single nucleotide substitutions and small deletions or insertions (1-20 bases) account for the majority of mutations in the BRCA2 gene. Most of these alterations result in a truncated form of the breast cancer type 2 susceptibility protein. Mutations in the BRCA2 gene predispose males to breast cancer. | BRCA2 Gene Mutation|Mutation of the BRCA2 Gene|BRCA2 Mutation|BRCC2 Gene Mutation|BROVCA2 Gene Mutation|Breast Cancer Type 2 Susceptibility Gene Mutation|FANCD1 Gene Mutation|Breast Cancer 2 Gene Mutation|Breast Cancer 2, Early Onset Gene Mutation | BRCA2 Gene Mutation |
C0376672 | null | null | Outtakes |
C0376672 | null | null | Outtakes |
C0969448 | null | null | canadensolide |
C0969448 | null | null | canadensolide |
C0016390 | Lipid-laden macrophages originating from monocytes or from smooth muscle cells. | Foam cell|foam cell|Foam Cells|Foamy Macrophage|cell foam|Cells, Foam|Foamy macrophages|Foam cell (cell)|Cell, Foam|Foam Cell|foam cells | Foam Cells |
C1154599 | A phenomenon where microorganisms communicate and coordinate their behavior by the accumulation of signaling molecules. A reaction occurs when a substance accumulates to a sufficient concentration. This is most commonly seen in bacteria. | quorum sensing|quorum sensing system|QS|Sensing, Quorum|Quorum Sensing | quorum sensing |
C1135598 | null | Postnatal development | postnatal development |
C0963864 | null | adenylyl cyclase type 5|AC5 enzyme | adenylyl cyclase type V |
C0379099 | Proton-translocating ATPases that are involved in acidification of a variety of intracellular compartments. | Lysosomal F(1)F(0) ATPase|Vacuolar Membrane H(+)-ATPase|Vacuolar F(1)F(0) ATPase|Lysosomal Proton Translocating ATPases|Vacuolar H+-ATPase|Vacuolar F(1)F(0) ATPases|Vacuolar H+ ATPase|Vacuolar Proton-Translocating ATPases|ATPase, Vacuolar|ATPase, V-Type|H+-ATPase, Vacuolar|vacuolar h+-atpase|atpases vacuolar|Lysosomal Proton-Translocating ATPases|V Type ATPase|Proton-Translocating ATPases, Lysosomal|V-Type ATPase|ATPases, Lysosomal Proton-Translocating|Vacuolar ATPase | vacuolar H+-ATPase |
C0006685 | Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue. | Ion Channel, Calcium|VDCC|calcium channel|Receptors, Calcium Channel Blocker|Calcium channels|Calcium Channel|Calcium Ion Channels|Calcium Channel Blocker Receptors|Channels, Voltage-Dependent Calcium|calcium ion channel|calcium channels|Calcium Channels|Calcium Ion Channel|Receptors, Calcium Channel Antagonist|Voltage Dependent Calcium Channels|Calcium Channels, Voltage-Dependent|Calcium Channel Antagonist Receptors|Voltage-Dependent Calcium Channels|Calcium Channel Blocker Receptor|Ion Channels, Calcium|Calcium Channel Antagonist Receptor | Calcium Channel |
C0006685 | Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue. | Ion Channel, Calcium|VDCC|calcium channel|Receptors, Calcium Channel Blocker|Calcium channels|Calcium Channel|Calcium Ion Channels|Calcium Channel Blocker Receptors|Channels, Voltage-Dependent Calcium|calcium ion channel|calcium channels|Calcium Channels|Calcium Ion Channel|Receptors, Calcium Channel Antagonist|Voltage Dependent Calcium Channels|Calcium Channels, Voltage-Dependent|Calcium Channel Antagonist Receptors|Voltage-Dependent Calcium Channels|Calcium Channel Blocker Receptor|Ion Channels, Calcium|Calcium Channel Antagonist Receptor | Calcium Channel |
C0004589 | A species of bacteria that causes ANTHRAX in humans and animals. | anthracis b.|Bacillus Anthracis|B. anthracis|anthracis b|Anthrax bacillus|Bacillus anthracis|anthrax bacterium|Bacteridium anthracis|BACILLUS ANTHRACIS|bacillus anthrax|b. anthracis|Bacillus anthracis (organism)|anthracis bacillus|Bacillus cereus var. anthracis|bacillus anthracis | Bacillus anthracis |
C0000912 | null | Accident caused by unspecified fire|fire accident|Burning NOS|fire | Accident caused by unspecified fire |
C0017978 | Lipids containing at least one monosaccharide residue and either a sphingoid or a ceramide (CERAMIDES). They are subdivided into NEUTRAL GLYCOSPHINGOLIPIDS comprising monoglycosyl- and oligoglycosylsphingoids and monoglycosyl- and oligoglycosylceramides; and ACIDIC GLYCOSPHINGOLIPIDS which comprises sialosylglycosylsphingolipids (GANGLIOSIDES); SULFOGLYCOSPHINGOLIPIDS (formerly known as sulfatides), glycuronoglycosphingolipids, and phospho- and phosphonoglycosphingolipids. (From IUPAC's webpage) | Asialogangliosides|asialoganglioside|Glycosphingolipids|Sphingoglycolipids|Glycosphingolipid|glycosphingolipids|glycosphingolipid | Glycosphingolipids |
C0175727 | null | stimulator|Stimulator, device|stimulators|Stimulator, device (physical object)|Stimulator, NOS|stimulator [device]|Stimulator|Stimulators | Stimulator |
C0002357 | Consideration and concern for others, as opposed to self-love or egoism, which can be a motivating influence. | Altruism - mental defense mechanism|Altruism - mental defense mechanism (finding)|Altruism|Altruism - mental defence mechanism|altruism | Altruism |
C0030106 | The unstable triatomic form of oxygen, O3. It is a powerful oxidant that is produced for various chemical and industrial uses. Its production is also catalyzed in the ATMOSPHERE by ULTRAVIOLET RAY irradiation of oxygen or other ozone precursors such as VOLATILE ORGANIC COMPOUNDS and NITROGEN OXIDES. About 90% of the ozone in the atmosphere exists in the stratosphere (STRATOSPHERIC OZONE). | O>3<|O3 - ozone|Ozone (substance)|O3|O<sub>3</sub>|ozone (O3)|Ozone|ozono|ozone | Ozone |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.